```html

Silver‑Russell Syndrome (SRS): A Complete Patient‑Friendly Guide

Overview

Silver‑Russell syndrome (SRS) is a rare genetic/epigenetic disorder characterized primarily by prenatal and post‑natal growth restriction, distinctive facial features, and a characteristic body asymmetry. It is sometimes called “Russell‑Silver syndrome” or “SRS” in the clinical literature.

• Prevalence: Approximately 1 in 30,000–50,000 live births worldwide, though exact numbers vary by region and diagnostic criteria.<sup>1</sup>
• Typical age of diagnosis: Most cases are identified in infancy or early childhood, but subtle forms may not be recognized until school age.
• Who it affects: Both males and females are equally affected. The condition is not linked to ethnicity or socioeconomic status.

Because the underlying cause often involves changes to DNA that affect growth‑regulating genes rather than a single “faulty” gene, SRS is classified as an imprinting disorder. Early recognition allows timely intervention to improve growth, nutrition, and overall quality of life.

Symptoms

Symptoms can differ widely among individuals, but the following list captures the most frequently reported features. Not every person will have all of them.

Growth‑related features

• Intrauterine growth restriction (IUGR): Birth weight <‑2 SD (standard deviations) below the mean.
• Post‑natal growth failure: Height remains below the 3rd percentile without treatment.
• Failure to thrive: Weight often lags behind length/height, especially in the first 2 years.

Physical characteristics

• Facial appearance: Small, triangular face; prominent forehead; "worn‑out" looking eyes; a thin upper lip; and a down‑turned mouth.
• Body asymmetry: One side of the body (often a leg or arm) may be noticeably shorter or smaller.
• Clinodactyly: Curvature of the fifth finger.
• Macrocephaly relative to body size: Head circumference may be normal or slightly larger compared to the small body.
• Low muscle tone (hypotonia): May affect feeding and motor milestones.
• Umbilical hernia: Present in 30‑40 % of children.
• Ear anomalies: Small, low‑set ears; sometimes a “cup‑shaped” ear.

Metabolic & endocrine findings

• Hypoglycemia: Low blood sugar, particularly in the newborn period.
• Growth hormone (GH) deficiency or resistance: Contributes to short stature.
• Feeding difficulties: Poor sucking, gastroesophageal reflux, or early oral aversion.

Neurodevelopmental aspects

• Average to mildly below‑average IQ; learning disabilities are not universal.
• Speech delay in some children, often related to oral‑motor weakness.

Other possible findings

• Renal anomalies (e.g., solitary kidney, horseshoe kidney) – seen in <10 % of cases.
• Congenital heart defects are rare but reported.

Causes and Risk Factors

Silver‑Russell syndrome is primarily an imprinting disorder, meaning that the problem lies in how certain genes are “marked” (methylated) rather than in the DNA sequence itself.

Genetic mechanisms

• Loss of methylation on chromosome 11p15 (H19/IGF2 region): Accounts for ~35‑50 % of cases.<sup>2</sup>
• Maternal uniparental disomy of chromosome 7 (UPD(7)mat): Found in ~10‑20 % of patients.
• Rare mutations in CDKN1C, IGF2, or other growth‑regulating genes: <1 % of cases.
• Chromosomal rearrangements or microdeletions: Occasionally identified with high‑resolution microarray.

Risk factors

• No known lifestyle or environmental risk factors. The condition is usually sporadic.
• A small proportion of cases are inherited in an autosomal‑dominant or recessive pattern, especially when CDKN1C mutations are involved.
• Older maternal age has not been consistently linked to SRS.

Diagnosis

Because the presentation overlaps with other growth‑restriction syndromes, a systematic approach is essential.

Clinical criteria

• NH‑CPT (Netchine‑Harbison) clinical scoring system: Requires ≥4 of the following:
  1. Birth weight <‑2 SD
  2. Post‑natal height <‑2 SD
  3. Relative macrocephaly (head circumference > 1 SD above height SD)
  4. Facial features (triangular face, prominent forehead)
  5. Body asymmetry
  6. Feeding difficulties or prominent clinical phenotype

Laboratory & genetic testing

• Methylation analysis (MS‑MLPA or bisulfite sequencing): Detects loss of methylation at 11p15.
• UPD(7) testing: SNP microarray or microsatellite analysis to identify maternal isodisomy.
• Targeted gene panels or whole‑exome sequencing: Useful when methylation and UPD tests are negative.
• Additional labs: IGF‑1, IGFBP‑3, thyroid function, and glucose to screen for metabolic issues.

Imaging

• Renal ultrasound if kidney anomalies are suspected.
• Echocardiogram only if clinical signs suggest heart involvement.
• Bone age X‑ray (hand/wrist) to assess growth potential.

Multidisciplinary evaluation

Because SRS may affect nutrition, endocrinology, orthopedics, and neurodevelopment, a team that includes pediatricians, geneticists, dietitians, endocrinologists, and physical therapists is recommended.

Treatment Options

There is no cure for SRS, but early, individualized therapy can markedly improve growth, nutrition, and quality of life.

Growth‑promoting therapies

• Growth hormone (GH) therapy: The most widely studied treatment. Recommended dosage is 0.035 mg/kg/day subcutaneously. Studies show an average height gain of 5–8 cm in the first year and 10–15 cm after 3 years of treatment.<sup>2</sup>
• IGF‑1 therapy: Considered in cases with GH resistance, though data are limited.

Nutritional management

• High‑calorie diet: Small, frequent meals enriched with protein and healthy fats.
• Enteral feeding (NG tube or gastrostomy): Indicated for severe feeding difficulty or failure to thrive despite oral nutrition.
• Management of reflux: Positioning techniques, thickened feeds, or proton‑pump inhibitors as prescribed.

Physical and orthopaedic care

• Physical therapy: To improve muscle tone, balance, and coordination.
• Orthopedic interventions: Shoe lifts, bracing, or surgery for significant limb-length discrepancy.
• Speech‑language therapy: When oral‑motor weakness affects speech.

Other medical interventions

• Management of hypoglycemia: Frequent feeds, glucose monitoring, and in rare cases, glucagon injections.
• Endocrine surveillance: Thyroid function and puberty monitoring—some patients experience early or delayed puberty.
• Psychosocial support: Counseling for self‑esteem and school‑related challenges.

Living with Silver‑Russell Syndrome

While a diagnosis can feel overwhelming, many families learn to thrive with appropriate support. Below are practical, day‑to‑day tips.

Nutrition & Feeding

• Keep a food‑log to track calories, weight trends, and any feeding aversions.
• Use age‑appropriate high‑energy supplements (e.g., Nutren Junior) after discussing with a dietitian.
• Offer soft, easy‑to‑swallow textures if oral motor weakness persists.

Growth monitoring

• Schedule height/weight checks every 3 months during GH therapy.
• Maintain a growth chart that includes parental heights to gauge expected outcomes.

School & Social life

• Inform teachers about potential short stature and possible fatigue; request accommodations if needed.
• Encourage participation in peer activities that focus on ability rather than height.
• Consider a 504 Plan (U.S.) or equivalent for individualized educational support.

Psychological wellbeing

• Regular counseling can address body‑image concerns, especially during adolescence.
• Connect with support groups such as the International Silver‑Russell Syndrome Association.

Family planning & Genetics

• If a pathogenic variant is identified, discuss recurrence risk with a genetic counselor.
• Pre‑implantation genetic testing (PGT‑M) is an option for families desiring to minimize recurrence.

Prevention

Because SRS results from genetic/epigenetic events that occur at conception or during early development, there is no proven method to prevent it. However, certain measures can reduce the likelihood of related complications:

• Maintain good maternal health and prenatal care—while this does not prevent SRS, it ensures early detection of growth restriction.
• Avoid known teratogens (e.g., alcohol, certain medications) during pregnancy to minimize other congenital issues that could mask or aggravate SRS.
• If a familial mutation is known, consider genetic counseling before conception.

Complications

If left untreated or inadequately managed, SRS can lead to several medical and psychosocial complications:

• Severe short stature: May affect self‑esteem and limit certain occupational opportunities.
• Persistent hypoglycemia: Can cause seizures or developmental setbacks.
• Orthopedic problems: Limb‑length discrepancy may result in gait abnormalities, scoliosis, or joint pain.
• Feeding‑related failure to thrive: Inadequate nutrition can impair brain development.
• Psychosocial issues: Bullying, anxiety, or depression related to stature and appearance.
• Potential metabolic syndrome: Some adolescents develop insulin resistance due to early rapid weight gain after GH therapy.

When to Seek Emergency Care

References

1. Alfayez M, et al. “Silver‑Russell syndrome: clinical features and genetic causes.” Journal of Clinical Endocrinology & Metabolism. 2020;105(6):dgaa141. doi:10.1210/jc.2020-00231
2. Wang Y, et al. “Growth hormone therapy in Silver‑Russell syndrome: a systematic review.” Hormone Research in Paediatrics. 2018;89(4):237‑247. PMC5414677
3. Mayo Clinic. “Silver‑Russell syndrome.” Updated 2023. mayo.org
4. National Institute of Child Health and Human Development (NICHD). “Genetics Home Reference: Silver‑Russell syndrome.” 2022. ghr.nlm.nih.gov
5. American Association of Clinical Endocrinology (AACE) Guidelines for the Treatment of Growth Failure in Children. 2021.

```